[1] WALDENSTROM J. Liver,blood proteins and food proteins[J]. Dtsch Z Verdau Stoffwechselkr,1952,12(Spec No):113-121.
|
[2] MANNS MP,LOHSE AW,VERGANI D. Autoimmune hepatitis—update 2015[J]. J Hepatol,2015,62(1 Suppl):s100-s111.
|
[3] HENEGHAN MA,YEOMAN AD,VERMA S,et al. Autoimmune hepatitis[J]. Lancet,2013,382(9902):1433-1444.
|
[4] ALVAREZ F,BERG PA,BIANCHI FB,et al. International Autoimmune Hepatitis Group Report:Review of criteria for diagnosis of autoimmune hepatitis[J]. J Hepatol,1999,31(5):929-938.
|
[5] HENNES EM,ZENIYA M,CZAJA AJ,et al. Simplified criteria for the diagnosis of autoimmune hepatitis[J]. Hepatology,2008,48(1):169-176.
|
[6] MACK CL,ADAMS D,ASSIS DN,et al. Diagnosis and management of autoimmune hepatitis in adults and children:2019practice guidance and guidelines from the American Association for the study of liver diseases[J]. Hepatology,2019.[Epub ahead of print]
|
[7] LIBERAL R,KRAWITT EL,VIERLING JM,et al. Cutting edge issues in autoimmune hepatitis[J]. J Autoimmun,2016,75:6-19.
|
[8] FLOREANI A,de MARTIN S,SECCHI MF,et al. Extrahepatic autoimmunity in autoimmune liver disease[J]. Eur J Intern Med,2019,59:1-7.
|
[9] MIELI-VERGANI G,VERGANI D,CZAJA AJ,et al. Autoimmune hepatitis[J]. Nat Rev Dis Primers,2018,4:18017.
|
[10] European Association for the Study of the Liver. EASL clinical practice guidelines:Autoimmune hepatitis[J]. J Hepatol,2015,63(4):971-1004.
|
[11] LIBERAL R,GRANT CR,LONGHI MS,et al. Diagnostic criteria of autoimmune hepatitis[J]. Autoimmun Rev,2014,13(4-5):435-440.
|
[12] VERGANI D,ALVAREZ F,BIANCHI FB,et al. Liver autoimmune serology:A consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group[J]. J Hepatol,2004,41(4):677-683.
|
[13] WASHINGTON MK. Autoimmune liver disease:Overlap and outliers[J]. Mod Pathol,2007,20(Suppl 1):s15-s30.
|
[14] GLEESON D,HENEGHAN MA,British Society of Gastroenterology. British Society of Gastroenterology(BSG)guidelines for management of autoimmune hepatitis[J]. Gut,2011,60(12):1611-1629.
|
[15] MIAO Q,BIAN Z,TANG R,et al. Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis[J]. Clin Rev Allergy Immunol,2015,48(2-3):226-235.
|
[16] GUINDI M. Histology of autoimmune hepatitis and its variants[J]. Clin Liver Dis,2010,14(4):577-590.
|
[17] HOFER H,OESTERREICHER C,WRBA F,et al. Centrilobular necrosis in autoimmune hepatitis:A histological feature associated with acute clinical presentation[J]. J Clin Pathol,2006,59(3):246-249.
|
[18] ZENG T,YU J,TAN L,et al. Noninvasive indices for monitoring disease course in Chinese patients with autoimmune hepatitis[J]. Clin Chim Acta,2018,486:135-141.
|
[19] MUSADDAQ G,SHAHZAD N,ASHRAF MA,et al. Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human[J]. Biomarkers,2019,24(2):103-109.
|
[20] EFE C,CENGIZ M,KAHRAMANOGˇLU-AKSOY E,et al. Angiotensin-converting enzyme for noninvasive assessment of liver fibrosis in autoimmune hepatitis[J]. Eur J Gastroenterol Hepatol,2015,27(6):649-654.
|
[21] KULLAK-UBLICK GA,ANDRADE RJ,MERZ M,et al. Drug-induced liver injury:Recent advances in diagnosis and risk assessment[J]. Gut,2017,66(6):1154-1164.
|
[22] HOOFNAGLE JH,BJORNSSON ES. Drug-induced liver injury-types and phenotypes. Reply[J]. N Engl J Med,2019,381(14):1396.
|
[23] WEILER-NORMANN C,SCHRAMM C. Drug induced liver injury and its relationship to autoimmune hepatitis[J]. J Hepatol,2011,55(4):747-749.
|
[24] CZAJA AJ. Drug-induced autoimmune-like hepatitis[J].Dig Dis Sci,2011,56(4):958-976.
|
[25] FONTANA RJ,SEEFF LB,ANDRADE RJ,et al. Standardization of nomenclature and causality assessment in drug-induced liver injury:Summary of a clinical research workshop[J]. Hepatology,2010,52(2):730-742.
|
[26] SUZUKI A,BRUNT EM,KLEINER DE,et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury[J]. Hepatology,2011,54(3):931-939.
|
[27] FEBRES-ALDANA CA,ALGHAMDI S,KRISHNAMURTHY K,et al. Liver fibrosis helps to distinguish autoimmune hepatitis from DILI with autoimmune features:A review of twenty cases[J]. J Clin Transl Hepatol,2019,7(1):21-26.
|
[28] BALA S,PETRASEK J,MUNDKUR S,et al. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic,drug-induced,and inflammatory liver diseases[J]. Hepatology,2012,56(5):1946-1957.
|
[29] WANG Y,TANG N,HUI T,et al. Identification of endogenous reference genes for RT-qPCR analysis of plasma microRNAs levels in rats with acetaminophen-induced hepatotoxicity[J].J Appl Toxicol,2013,33(11):1330-1336.
|
[30] CHALASANI N,YOUNOSSI Z,LAVINE JE,et al. The diagnosis and management of nonalcoholic fatty liver disease:Practice guidance from the American Association for the Study of Liver Diseases[J]. Hepatology,2018,67(1):328-357.
|
[31] CHALASANI N,YOUNOSSI Z,LAVINE JE,et al. The diagnosis and management of non-alcoholic fatty liver disease:Practice guideline by the American Gastroenterological Association,American Association for the Study of Liver Diseases,and American College of Gastroenterology[J]. Gastroenterology,2012,142(7):1592-1609.
|
[32] YATSUJI S,HASHIMOTO E,KANEDA H,et al. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease:Is the International Autoimmune Hepatitis Group scoring system useful?[J]. J Gastroenterol,2005,40(12):1130-1138.
|
[33] de LUCA-JOHNSON J,WANGENSTEEN KJ,HANSON J,et al. Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease[J]. Dig Dis Sci,2016,61(9):2710-2720.
|
[34] SUZUKI A,DIEHL AM. Nonalcoholic steatohepatitis[J]. Annu Rev Med,2017,68:85-98.
|
[35] TAO TY,GITLIN JD. Hepatic copper metabolism:Insights from genetic disease[J]. Hepatology,2003,37(6):1241-1247.
|
[36] GITLIN JD. Wilson disease[J]. Gastroenterology,2003,125(6):1868-1877.
|
[37] FERENCI P,CACA K,LOUDIANOS G,et al. Diagnosis and phenotypic classification of Wilson disease[J]. Liver Int,2003,23(3):139-142.
|
[38] WOIMANT F,DJEBRANI-OUSSEDIK N,POUJOIS A. New tools for Wilson’s disease diagnosis:Exchangeable copper fraction[J]. Ann Transl Med,2019,7(Suppl 2):s70.
|